Methotrexate Drug Card - Nursing Medication Guide

Methotrexate is a chemotherapy agent and immune system suppressant used in the treatment of certain types of cancer, severe psoriasis, and rheumatoid arthritis. It is crucial for nursing students to understand its usage, mechanism, and safety protocols due to its significant effects and potential for serious side effects. For the NCLEX exam, knowledge of methotrexate’s indications and nursing considerations is essential, as questions often focus on safe administration and patient education.

Methotrexate belongs to the pharmacologic class of antimetabolites and is therapeutically classified as an antineoplastic and immunosuppressant. Its mechanism of action involves inhibiting the enzyme dihydrofolate reductase, which is necessary for DNA synthesis and cell replication. By blocking this enzyme, methotrexate interferes with the growth of rapidly dividing cells, such as cancerous cells and certain cells of the immune system.

Methotrexate is commonly used to treat certain types of cancer including breast, head and neck, lung, and certain blood cancers like leukemia. It is also prescribed for severe psoriasis and rheumatoid arthritis, where it helps to reduce inflammation and slow disease progression. In these contexts, methotrexate is typically used when other treatments have not been effective.

Before administering methotrexate, it is important to assess the patient’s liver function, renal function, and complete blood count (CBC) to establish a baseline and identify any contraindications or potential for adverse effects. During therapy, nurses should monitor for signs of bone marrow suppression, hepatotoxicity, and nephrotoxicity. It is also essential to ensure that patients remain well-hydrated to prevent renal impairment and to educate them on potential drug interactions, especially with NSAIDs, which can increase methotrexate toxicity.

Common side effects of methotrexate include nausea, vomiting, stomatitis, and fatigue. More serious adverse reactions can include bone marrow suppression leading to anemia, leukopenia, and thrombocytopenia, as well as hepatotoxicity and pulmonary toxicity. Nurses must be vigilant in monitoring for these serious side effects and intervene as necessary, such as adjusting doses or discontinuing the drug in consultation with the healthcare provider.

Patients taking methotrexate should be educated on the importance of regular blood tests to monitor for toxicity. They should be advised to report any signs of infection or unusual bleeding or bruising immediately. Patients should also be instructed to avoid alcohol due to the increased risk of hepatotoxicity and informed about the potential need for folic acid supplementation to minimize side effects like mouth sores.

Methotrexate frequently appears on the NCLEX in questions about cancer treatment protocols, immunosuppressive therapy, and management of rheumatoid arthritis. Key points include its mechanism of action, side effects, and necessary monitoring parameters. Questions may also cover patient education, particularly around the importance of adherence to lab monitoring and recognizing signs of toxicity.

Hydroxychloroquine Drug Card Rheumatoid Arthritis Care Plan NCLEX Pharmacology Prep